Last updated:
ID:
65846
Start date:
11 January 2021
Project status:
Closed
Principal investigator:
Dr Mattia Quattrocelli
Lead institution:
Cincinnati Children's Hospital Medical Center, United States of America

Glucocorticoid steroids are widely used drugs to manage inflammation in many conditions. Chronic intake of these drugs promotes untoward side effects, like osteoporosis, obesity, growth suppression and hypertension. These steroids act through a receptor called glucocorticoid receptor, encoded by the gene NR3C1. This 3-year-long project aims at evaluating whether genetic variants in this gene correlate with alterations of metabolism or function. The results of this study may pave the way to better understand how we respond to these drugs and how we can counteract their side effects.

Related publications

Author(s)
Hima Bindu Durumutla, April Haller, Greta Noble, Ashok Daniel Prabakaran, Kevin McFarland, Hannah Latimer, Akanksha Rajput, Olukunle Akinborewa, Bahram Namjou-Khales, David Y. Hui, Mattia…
Journal
Journal of Clinical Investigation
  • heart and blood vessels
Author(s)
Ashok Daniel Prabakaran, Fabian Montecino-Morales, Kevin McFarland, Thirupugal Govindarajan, Hima Bindu Durumutla, Hannah Latimer, Olukunle Akinborewa, Chiara Villa, Douglas P. Millay, Mattia Quattrocelli
Journal
Science Advances
  • nutrition and metabolism

All publications